Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025). Rev Alerg Mex [Internet]. 2025 Mar. 31 [cited 2026 Sep. 24];72(1):52-71. Available from: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/1433